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Background: In designing responses to the COVID-19 pandemic, it is 
critical to understand what has already worked well. We aimed to 
identify countries with emerging success stories from whom 
policymakers might draw important lessons.  
Methods: We developed a process to first include countries with large 
enough populations that results were unlikely to be due to chance, 
that had sufficient cases for response mechanisms to be tested, and 
that shared the necessary publicly available data. Within these 
countries, we looked at indicators suggesting success in terms of 
detecting disease, containing the outbreak, and treating those who 
were unwell. To support comparability, we measured indicators per 
capita (per million) and across time. We then used the indicators to 
identify three countries with emerging success stories to include some 
diversity in global region, population demographics and form of 
government. 
  
Results: We identified 66 countries that met our inclusion criteria on 
18th May 2020. Several of these countries had indicators of success 
against the set indicators at different times in the outbreak. Vietnam 
had high levels of testing and successful containment with no deaths 
reported. South Korea had high levels of testing early in the outbreak, 
supporting containment. Germany had high levels of sustained 
testing and slower increases in cases and deaths than seen in other 
comparable settings. 
Conclusions: At the time of our assessment, Vietnam and South Korea 
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were able to contain the outbreak of COVID-19 and avoid the 
exponential growth in cases seen elsewhere. Germany had more 
cases and deaths, but was nevertheless able to contain and mitigate 
the outbreak. Despite the many limitations to the data currently 
available, looking at comparative data can help identify countries from 
whom we can draw lessons, so that countries can inform and adapt 
their strategies for success in response to COVID-19.
Keywords 
COVID-19, pandemic, lessons, exemplars, outbreak, response, 
learning
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Introduction
A cluster of cases of pneumonia of unknown aetiology were 
identified in December 2019 in Wuhan, China1. These cases 
were found to be caused by a novel coronavirus, SARS-CoV-2. 
The outbreak of coronavirus disease 2019 (COVID-19) contin-
ued, and with cases identified across the world, the outbreak was 
declared a Public Health Emergency of International Concern by 
the World Health Organization (WHO) on January 30th, 20202. 
At that time, there were 7,711 confirmed cases and 170 deaths 
in China, then the epicentre. Outside of China, 83 cases had 
been reported in 18 countries, with community transmission 
reported in three of these countries3. Further spread led to the 
declaration of a pandemic on March 11th, 2020. By the end of 
April 2020, there were over 3 million cases and over 200,000 
deaths reported in 213 countries, areas or territories2.
In mid-March the WHO Strategic and Technical Advisory 
Group for Infectious Hazards recommended that “all coun-
tries should consider a combination of response measures: case 
and contact finding; containment or other measures that aim 
to delay the onset of patient surges where feasible; and meas-
ures such as public awareness, promotion of personal protective 
hygiene, preparation of health systems for a surge of severely 
ill patients, stronger infection prevention and control in 
health facilities, nursing homes, and long-term care facilities, 
and postponement or cancellation of large-scale public 
gatherings.”4 Preparedness to support these activities, and the 
strategies used, have varied. Whilst recognising that differ-
ent contexts require different approaches5, we aimed to develop 
criteria to identify countries that have limited the impact of 
COVID-19 as “success stories” with valuable lessons to share 
to other countries.
Methods
We assembled a group with expertise in public health policy, 
infectious diseases, outbreak response, and data analytics 
to develop a process to identify countries with emerging 
success in their response to COVID-19.
Countries from which others can potentially learn
To be considered as an emerging success in our analysis, we 
only included countries meeting three key criteria. Firstly, 
to ensure that results in indicators were unlikely to be due to 
chance, and generalisable, we only included countries with 
populations over 5 million people. Secondly, we wanted to 
include countries with sufficient cases to demonstrate suc-
cess, whilst recognizing that in some countries, low preva-
lence may be the result of effective containment, so we only 
included countries which had had at least 100 confirmed 
cases 21 days before our analysis. Thirdly, although data on 
COVID-19 cases and deaths are widely available, data on test-
ing are less so and these data are essential to our analysis 
across the detect, contain, and treat phases, so we only included 
countries publishing testing data.
We used these three criteria as a first filter to identify coun-
tries with emerging success from all countries worldwide. 
Data were extracted on 18th May 2020, from those curated by 
Our World In Data (https://ourworldindata.org/coronavirus), 
based on daily published figures of cases and deaths from the 
European Centre for Disease Control. Population adjustments 
for per capita comparisons were made based on population data 
from the United Nations Population Division6. The database 
on testing was curated by Our World in Data based on informa-
tion from public sources, including official websites, in press 
releases and by social media accounts of national authorities 
—usually governments, ministries of health, or centres for 
disease control7.
Countries with indicators of success in response to 
COVID-19
We then considered indicators which could reflect successful 
interventions to COVID-19. The Global Health Security Index 
(GHSI) is a tool to assess countries’ health security, consider-
ing broad risks as well as geopolitical considerations, the health 
system, and whether the capacity to contain outbreaks has been 
tested8. It describes six categories: prevention, detection, rapid 
reporting, health system, compliance with international norms, 
and risk environment. Because transmission of COVID-19 is 
ongoing, it is too soon to determine if any country will ulti-
mately succeed at prevention, so we excluded the prevention 
phase from our analysis and focused on three categories: detect, 
contain and treat. We cross-referenced these three categories 
to key actions from the WHO’s “Strategic preparedness and 
response plan for the novel coronavirus” and then, based on the 
key actions, we selected indicators specific to COVID-19 that 
could be used to assess success in a country’s response (Table 1)9.
Principles for comparison
In doing this, we followed some general principles to ensure 
fair comparisons could be made between countries. Firstly, we 
used per capita indicators to account for the country’s popula-
tion. Secondly, we primarily used absolute dates (calendar dates) 
instead of relative dates (for example the number of days 
since a certain number of deaths), reflecting the fact that all 
countries were aware of events worldwide at the same time.
Detect. Testing strategies may differ during an outbreak. For 
example, when there are fewer cases and the aim is to contain 
the outbreak by contact tracing, a high number of tests per case 
may increase the chance of successful containment. If the out-
break has progressed to widespread community transmission and 
it is not feasible to trace all contacts of positive cases, then high 
levels of testing may not be as critical for community control. 
In this situation, in many places, population-wide restric-
tions are in place to reduce spread across the population rather 
than specifically targeting contacts of confirmed cases. There 
are many challenges with counting cases, not least because 
this will depend on the availability of testing and the ability to 
detect those with no or mild symptoms9. Counting and detect-
ing deaths is likely to be a more accurate measure of the spread 
of the infection than cases. Based on these considerations, we 
defined key indicators for the “Detect” phase as i) the number 
of tests per capita against time, ii) the number of tests per 
confirmed case, and iii) the number of tests per confirmed 
death with COVID-19 per capita.
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Contain. Although identifying people with COVID-19 depends 
on a country’s testing strategy and testing capacity, relative 
to its population, we felt that review of case data was still impor-
tant. Case doubling time may be less affected by testing capacity 
than case per capita, as long as testing capacity has not changed 
substantially or is at its maximum. However, as testing capac-
ity has indeed changed over time, which may be reflected in an 
increase in cases, we also included deaths in our indicators for the 
“Contain” phase, since these are likely to have been tested and 
recorded more completely than cases. We included people with 
confirmed COVID-19 infection (cases) as an outcome in terms 
of iv) confirmed cases per capita against time and v)confirmed 
cases per capita compared to confirmed case doubling 
time (7-day period), and people with confirmed death from 
COVID-19 in terms of vi) confirmed COVID-19 deaths per 
capita and vii) confirmed COVID-19 deaths per capita 
compared to confirmed death doubling time (7-day period).
Treat. There are many reporting biases when calculating the 
case fatality rate (CFR)11,12. For example, the number of cases 
(denominator) will depend on the number of tests being done in 
total, and who is being tested. Countries testing many people, 
or which include those who are asymptomatic or mildly ill (an 
infection fatality rate), will appear to have a lower CFR than coun-
tries testing only those who seek health care or are hospitalised, for 
example. There is also a delay between when people are infected 
and when they die. In countries going towards the epidemic 
peak, CFR will be underestimated because many people who 
will eventually die are still in the community or are hospitalised 
with severe infection13. There are also true demographic differ-
ences; countries with older populations or a high proportion of 
comorbidities have more people vulnerable to severe disease, 
and thus higher CFRs may be due to this, rather than inadequate 
treatment14,15. While recognising these issues, we selected indi-
cators to assess efforts to limit the number of deaths relative to 
Table 1. Indicators for evaluating country performance cross referenced against the Global Health Security Index, WHO 
response pillars and the phases of response.
GHSI Response 
phase10
Key actions WHO Pillars Indicators Exemplars
Prevent Prepare 1,5
Detect Contain Detection of cases 1,4,5 
 
1,3,4
Total COVID-19 tests per 1,000 people
 
Number of COVID-19 tests per confirmed case 
 
Total COVID-19 tests vs. Confirmed deaths per 
million people
Detect
Respond Contain Isolation of suspected 
cases, contact tracing
1,6,7 Total confirmed COVID-19 cases per million people 
 
Total confirmed COVID-19 cases per million vs. 
Doubling time of total confirmed cases (7-day 
period) 
 
Total confirmed COVID-19 deaths per million 
people 
 
Total confirmed COVID-19 deaths per million vs. 
Doubling time of confirmed deaths (7-day period),
Contain
Healthcare Mitigate Case management 
Health care capacity
1,7,8 Case-fatality rate of the ongoing COVID-19 
pandemic 
 
Total confirmed COVID-19 deaths vs. cases
Treat
WHO Pillars
Pillar 1- Country level coordination, planning, monitoring
Pillar 2 – Risk communication and community engagement
Pillar 3 - Surveillance, Rapid Response Teams, And Case Investigation
Pillar 4 - Points of Entry
Pillar 5 – National laboratories
Pillar 6 - Infection Prevention and Control
Pillar 7 - Case Management
Pillar 8 - Operational Support and Logistics
GHSI=Global Health Security Index; WHO=World Health Organization
Page 4 of 14
Gates Open Research 2020, 4:62 Last updated: 03 FEB 2021
the number of cases detected and how these changed over time; 
viii) case fatality rate over time and ix) confirmed COVID-19 
deaths compared to cases.
Countries representing diverse regions and key intrinsic 
factors
We examined the countries that met our inclusion criteria against 
each of the nine indicators at specific time points (i.e., fixed cal-
endar dates) to reflect, for example, countries with high testing 
capacity early on in the outbreak (January and February 2020), 
and countries moving through the phases of the outbreak. 
From this shortlist, we selected three countries with emerging 
success stories, also reflecting diverse geographic regions and 
varied intrinsic factors such as land and sea borders and differing 
political structures. This final decision for selection was to 
support learning from these countries relevant to as many other 
countries as possible.
Results
Countries from which others can potentially learn
On May 18th 2020, 123 countries met the population size 
criterion (Figure 1a), 98 met the total number of cases cri-
terion (Figure 1b) and 66 reported testing data (Figures 1c). 
Although all African countries have reported cases of 
COVID-19, few have yet reached 21 days since their 100th 
confirmed case and even fewer are reporting testing data so 
the continent is under-represented in this analysis.
Identifying countries with indicators of success
Detect. We looked at total COVID-19 tests per 1,000 people 
against time, number of COVID-19 tests per confirmed 
case and total COVID-19 tests against confirmed deaths per 
million people (Figure 2). South Korea had high testing per 
confirmed case during January and February 2020, as did the 
United Kingdom. Capacity in South Korea continued to increase 
(Figure 2a), but Germany had higher capacity than both South 
Korea and the UK in mid-March, as Europe was declared the 
COVID-19 epicentre. Germany’s testing continued to rapidly 
increase, from 7 to 29 tests per million people by the end of 
April. South Korea also had a high ratio of tests to confirmed 
cases early in the outbreak, decreasing as large clusters of infec-
tion developed during early March. In early May, Vietnam, 
was performing very strongly in terms of the number of 
tests per confirmed case (Figure 2b). Australia also had 
high levels of testing, and when Australia recorded its first 
COVID-19 death, it had conducted 5,610 tests per million 
people, the highest among countries meeting our criteria 
(Figure 2c).
Contain. We looked at total confirmed COVID-19 cases 
per million people, confirmed COVID-19 cases per million 
against doubling time of total confirmed cases (7-day period), 
confirmed COVID-19 deaths per million people against time and 
confirmed COVID-19 deaths per million against doubling time 
of confirmed deaths (7-day period) (Figure 3).
South Korea and Australia had very low cases of COVID-19 
per capita (215 cases per million and 276 cases per million, 
respectively) compared to the rest of the world, but Vietnam 
was even lower, with only 3 cases per million (Figure 3a). 
Cases have peaked at different times worldwide, and as the 
number of new cases begins to reduce across Europe and North 
America (April/May 2020), other countries are seeing rapid 
increases in confirmed cases, for example Brazil (Figure 3a). 
For deaths, similar patterns emerge; Vietnam has not recorded 
any deaths with COVID-19 while South Korea and Aus-
tralia have low numbers of deaths per capita compared to the 
rest of the world. This is in contrast to many European coun-
tries, with Belgium reporting the highest number of deaths 
per million people (786) (Figure 3b). Some of the countries 
recording a very high number of deaths from COVID-19 
have passed the peak cases and doubling times for deaths are 
increasing, for example in Italy. (Figure 3c).
Treat. We looked at total confirmed COVID-19 deaths compared 
to cases, and case fatality rate (CFR) against time (Figure 4). 
South Korea reported only 263 deaths from 11,065 cases, a 
CFR of 2.4%. Germany reported substantially more deaths 
(7,935) and cases (174,697), a CFR of 4.5%, below the global 
average of 6.7%. Neither country had an apparent rapid increase 
in CFR seen in several other countries. These increases may 
be caused by an inaccurate denominator for CFR due to low 
testing capacity in relation to increasing cases (Figure 4a). South 
Korea and Australia have limited cases and deaths as shown 
in Figure 4b. While there are limitations to assessing the 
CFR in COVID-1916, the high levels of testing in South Korea 
and Germany will increase accuracy compared to settings 
with lower testing.
Overall. Several countries have indicators of success and as 
the pandemic continues to evolve, success will be found in 
other countries. Through the process we applied, we identified 
Vietnam, South Korea, and Germany as three countries with 
emerging success stories. Vietnam has had high levels of testing 
and effective containment17. South Korea has also had high 
levels of testing and effective containment. Whilst Germany had 
a relatively large outbreak compared to South Korea and Viet-
nam, the number of cases and deaths per capita rose more slowly 
than other more similar European countries, and not to the 
same heights, suggesting success across detection, containment 
and treatment.
Conclusions
We developed selection criteria to identify countries with indi-
cators of success across current activities in relation to the 
COVID-19 outbreak. Several countries performed strongly 
in and across the three phases of detect, contain and treat. We 
identified Vietnam, South Korea and Germany as countries with 
indicators of success, and differing experiences, from whom 
lessons could be drawn. In these countries, high levels of 
testing early in the outbreak and continued increases in capac-
ity with rising cases, appear to have supported containment. 
Both Vietnam and South Korea have had experience of other 
zoonotic coronaviruses18, Severe acute respiratory syndrome 
coronavirus (SARS-CoV-1) and Middle East respiratory 
syndrome (MERS), respectively, which has likely supported 
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Figure 1. Countries assessed in this study. These world maps show countries with a) populations over 5 million people, b) at least 100 
confirmed people with COVID-19 21 days prior to assessment and c) published testing data. Updated graphs can be found here, here and 
here.
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Figure 2. Detect. These graphs show a) total COVID-19 tests per 1,000 people b) number of COVID-19 tests per confirmed case of 
COVID-19 c) total COVID-19 tests compared to confirmed deaths with COVID-19 per million people. Updated graphs can be found here, 
here and here.
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Figure 3. Contain. These graphs show a) total confirmed COVID-19 cases per million people b) total confirmed COVID-19 cases per 
million people compared to doubling time of total confirmed cases (7-day period) c) total confirmed COVID-19 deaths per million people 
against time d) total confirmed COVID-19 deaths per million compared to doubling time of confirmed deaths (7-day period). Updated 
graphs can be found here, here, here and here.
Page 8 of 14
Gates Open Research 2020, 4:62 Last updated: 03 FEB 2021
their response to COVID-1919; both countries rapidly scaled up 
capacity for testing20.
Although we sought to develop and apply objective indica-
tors in our analysis, we recognize limitations to our process. 
We may have excluded countries from whom other particular 
lessons could be drawn. We did not include Australia in the final 
selection, for example, due to its particular geography. Other 
countries were excluded based on population size, for exam-
ple Iceland and New Zealand. Iceland has very high testing 
per capita, and New Zealand quickly put in place widespread 
restrictions, and reported elimination of COVID-19 in May 
202021. Many African countries have not been included due to 
insufficient cases and limited availability of testing data at the 
time of analysis, who have used low-cost approaches22. 
Other countries, such as Sweden, have aimed to increase 
Figure 4. Treat. These graphs show a) case fatality rate against time b) Total confirmed COVID-19 deaths vs. cases. Updated graphs can 
be found here and here.
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The idea behind the study is very important: to rank countries by success in fighting their COVID-
19 epidemics. 
 
However, the manuscript presents only raw data without any statistical modeling. It is fairly well 
established that factors such as Age and comorbidities are important in determining the 
development of symptoms and the risk of hospitalization and death. The authors acknowledge 
this in the discussion, but the comparison between countries would be fairer if it was based on 
incidence and mortalities stratified by Age class. Co-morbidities are harder to control for, without 
having individual case data.
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The article 'COVID-19:Identifying countries with indicators of success in responding to the 
outbreak' examines different responses to COVID-19 and relative success, looking to explain key 
factors that might be critical to that success. In order to handle the diversity in demograpics 
population minimums, and case minimums and data availability were used as a filter for anlaysis. 
Success was judged on detection rates, containment, and treatment of cases and outcomes. To 
enable comparison, data was standardised indicators per capita per million and over time. 3 
countries were then selected as success stories showing diversity of region, demographic and 
governance. This is a relatively crude analysis but given the complexities in dealing with data 
comparabilities, well put together and it also recognises and states the weaknesses and need to 
re-examine the outcomes in the longer term. Nevertheless this analysis has shown considerable 
differences between states that might have been considered e.g. on GHSI to have similar 
strengths in the health systems and likely therefore to show similar outcomes. This was not the 
case and factors which determined success are not necessarily correlated with governance,  
relative wealth and capacity. The importance of sustained and consistent policy was also 
demonstrated in the initial testing response of the UK (high) and subsequent dropping of this in 
favour of other actions which was associated with a relatively poor outcome in the end for this 
country especially with respect to the successful countries highlighted, which used testing as a 
mainstay from the outset. 
 
There are no errors that I can detect in the data presented but some sentences would benefit with 
a fresh look to ensure clear expression and explanation. There is one statement which I think 
needs revision and this is in the conclusion where reference is made of other zoonotic 
coronaviruses. As no animal source has been confirmed for SARS - 1 or SARS - 2 and given all 
known cases have been transmitted human to human or from fomites and there is confirmed 
evidence only for zooanthroponosis (reverse zoonosis), it would be more accurate to state the 
probable zoonotic origins of SARS viruses rather than a zoonosis per se. An alternative more 
accurate description would be an emerging human pathogen and disease with probable zoonotic 
origins (the WHO definition of zoonosis is infection directly transmissible from animals to humans 
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with evidence of a permanent animal reservoir.) I recommend this article is indexed with minimal 
revision required. 
 
Correction to citation 18: R. A. Kock 
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